Christopher J. DePizzo focuses on mergers, acquisitions, joint ventures, corporate reorganizations, and other areas of corporate law. He represents private equity firms and other investors in leveraged buyouts, investments, dispositions, and portfolio management.
Chris also represents public and private companies across industries—including pharmaceuticals, consumer goods, technology, energy, software, retail, and sports—in mergers, divestitures, joint ventures, and market offerings, as well as assisting with ongoing business law and corporate governance issues. He has handled transactions involving—and has represented—companies spanning the corporate life cycle, from innovative start-ups to international market leaders.
Chris’s experience includes representing:
- A private equity firm in the acquisition of a wholesale distribution business
- A privately held pharmaceutical manufacturer in the prospective $8 billion sale to a global pharmaceutical company
- A private equity firm in the sale of an organic products manufacturer to an international consumer goods company
- A recreational vehicle, parts, and services company in its UP-C initial public offering of $32.6 million of common stock on the NYSE
Recognition & Accomplishments
Best Lawyers in America, "Ones to Watch," Mergers and Acquisitions Law, 2021-2023
Super Lawyers, "Rising Stars," 2021-2022
Board Memberships & Community Service
Member, Saint Peter’s University Board of Regents, 2015–2018
Member, Saint Peter’s University Board of Trustees, 2009–2010
University of Pennsylvania Law School (J.D., 2012)
University of Pennsylvania Wharton School of Business (Certificate in Business and Public Policy, 2012)
Saint Peter’s University (B.A., summa cum laude, 2009)